163 related articles for article (PubMed ID: 3914807)
1. Beta-cell function and diabetic control in insulin dependent diabetes melletus.
Faber OK
Acta Endocrinol Suppl (Copenh); 1985; 272():73-7. PubMed ID: 3914807
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.
Krarup T; Madsbad S; Moody AJ
J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559
[TBL] [Abstract][Full Text] [Related]
3. C-peptide: an index of insulin secretion.
Faber OK; Binder C
Diabetes Metab Rev; 1986; 2(3-4):331-45. PubMed ID: 3527619
[TBL] [Abstract][Full Text] [Related]
4. [Assay of C-peptide in diabetes in children and adolescents].
Jos J; Kestenbaum S
Ann Med Interne (Paris); 1984; 135(6):416-9. PubMed ID: 6391322
[TBL] [Abstract][Full Text] [Related]
5. Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes.
Sjöberg S; Ahrén B; Bolinder J
J Intern Med; 2002 Oct; 252(4):342-51. PubMed ID: 12366607
[TBL] [Abstract][Full Text] [Related]
6. [Hormonal function of islands of Langerhans in diabetes mellitus].
Balabolkin MI; Abrikosova SIu
Probl Endokrinol (Mosk); 1984; 30(5):16-8. PubMed ID: 6390424
[TBL] [Abstract][Full Text] [Related]
7. Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes.
Fernandez Castañer M; Montaña E; Camps I; Biarnes J; Merino JF; Escriba JM; Nacher V; Rosel P; Soler J
Diabetes Metab; 1996 Oct; 22(5):349-55. PubMed ID: 8896997
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-glucose (GG) test for the estimation of the insulin reserve in diabetes.
Miki H; Matsuyama T; Fujii S; Komatsu R; Nishioeda Y; Omae T
Diabetes Res Clin Pract; 1992 Nov; 18(2):99-105. PubMed ID: 1478158
[TBL] [Abstract][Full Text] [Related]
9. Functional rest through intensive treatment with insulin and potassium channel openers preserves residual beta-cell function and mass in acutely diabetic BB rats.
Rasmussen SB; Sørensen TS; Hansen JB; Mandrup-Poulsen T; Hornum L; Markholst H
Horm Metab Res; 2000 Jul; 32(7):294-300. PubMed ID: 10965937
[TBL] [Abstract][Full Text] [Related]
10. Residual B-cell function in type 1 (insulin-dependent) diabetes mellitus: its relation to clinical and metabolic features.
Bonora E; Coscelli C; Butturini U
Acta Diabetol Lat; 1984; 21(4):375-83. PubMed ID: 6397028
[TBL] [Abstract][Full Text] [Related]
11. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
Fukui M; Nakamura N; Nakano K; Kondo M
Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
[No Abstract] [Full Text] [Related]
12. Gastric inhibitory polypeptide (GIP): a therapeutic possibility?
Moody AJ; Jones IR; Krarup T; Owens DR; Saurbrey N
Acta Paediatr Scand Suppl; 1985; 320():66-71. PubMed ID: 3914816
[No Abstract] [Full Text] [Related]
13. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research.
Polonsky KS
Diabetes; 1995 Jun; 44(6):705-17. PubMed ID: 7789637
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between glucose utilization by tissues and residual insulin secretion and their role in the genesis of hyperglycemia in type I diabetes mellitus].
Starostina EG; Lobanova AM; Magomedova AK
Probl Endokrinol (Mosk); 1992; 38(3):15-8. PubMed ID: 1513782
[TBL] [Abstract][Full Text] [Related]
15. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
16. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes.
Madsbad S; Faber OK; Binder C; McNair P; Christiansen C; Transbøl I
Diabetes; 1978; 27 Suppl 1():262-4. PubMed ID: 344117
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients.
Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Jos J; Boitard C; Assan R; Robert JJ
Diabetes Care; 1995 Nov; 18(11):1487-90. PubMed ID: 8722075
[TBL] [Abstract][Full Text] [Related]
19. Residual beta-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve.
Clarson C; Daneman D; Drash AL; Becker DJ; Ehrlich RM
Diabetes Care; 1987; 10(1):33-8. PubMed ID: 3552512
[TBL] [Abstract][Full Text] [Related]
20. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
